Diabetes Metab J.  2012 Dec;36(6):412-414. 10.4093/dmj.2012.36.6.412.

Regional Adiposity, Adipokines, and Insulin Resistance in Type 2 Diabetes

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. jyoh@ewha.ac.kr

Abstract

No abstract available.


MeSH Terms

Adipokines
Adiposity
Insulin
Insulin Resistance
Adipokines
Insulin

Reference

1. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006. 444:881–887.
2. Aasen G, Fagertun H, Halse J. Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio. Scand J Clin Lab Invest. 2009. 69:505–511.
3. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010. 34:949–959.
4. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab. 2005. 90:4573–4578.
5. Snijder MB, Henry RM, Visser M, Dekker JM, Seidell JC, Ferreira I, Bouter LM, Yudkin JS, Westerhof N, Stehouwer CD. Regional body composition as a determinant of arterial stiffness in the elderly: the Hoorn Study. J Hypertens. 2004. 22:2339–2347.
6. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women. Eur Heart J. 2003. 24:1531–1537.
7. Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, Khaw KT. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr. 2005. 82:1203–1209.
8. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002. 45:1201–1210.
9. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism. 1991. 40:990–996.
10. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 1995. 27:435–438.
11. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001. 86:1930–1935.
12. Shay CM, Carnethon MR, Church TR, Hankinson AL, Chan C, Jacobs DR Jr, Lewis CE, Schreiner PJ, Sternfeld B, Sidney S. Lower extremity fat mass is associated with insulin resistance in overweight and obese individuals: the CARDIA study. Obesity (Silver Spring). 2011. 19:2248–2253.
13. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010. 299:E506–E515.
14. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Bluher M, Kahn BB. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 2007. 6:79–87.
15. Kim YL, Kim TK, Cheong ES, Shin DG, Choi GS, Jung J, Han KA, Min KW. Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes. Diabetes Metab J. 2012. 36:415–421.
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr